ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 753221 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 753221; 2) Community: the network communities that were significantly associated with the response to NSC 753221; 3) Molecule: the relationships between components within communities and NSC 753221; 4) MDR: the compounds that were significantly associated with the NSC 753221.

NSC Compound Enrichment Correlation
NSC 744331 (2R,11aS)-8- {2-[4-(2-{[(2R,11aS)-C2-di-Fluoro-7-Methoxy-5-oxo-2,3,5,11a-tetrahydro-1-H-benzo[e]-pyrrolo[1,2-a][1,4]diazepine-8-yl}propyl)piperazino]propoxy}-C2-di-fluoro-7-Methoxy-2,3,5,11a-tetrahyd 0.0058036595512194 0.21592635
NSC 747451 3,19-Benzylidine-14-deoxy-11,12-didehydroandrographolide 0.0058036595512194 0.40065616
NSC 758664 Sirolimus [USAN] 0.0058036595512194 -0.019391926
NSC 758682 ARTENIMOL 0.0058036595512194 0.36467476
NSC 668496 Null 0.00593538156800935 0.47303204
NSC 726195 2-phenyl 3-[(6-ethyl, 4-amino, 5-(4-chlorophenyl) pyrimidin-2-yl)] quinazolin-4-one 0.00593538156800935 0.25890205
NSC 151982 Null 0.00617256681787881 0.3715339
NSC 2039 Bioquin 0.00617256681787881 0.31494602
NSC 275971 Null 0.00617256681787881 0.66560078
NSC 329277 Null 0.00617256681787881 0.17442828
Total:93  Current:23    [First] [Prev] [Next] [Last]